OTR Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $104.77M |
|---|---|
| IPO Date | Nov 17, 2020 |
| CEO | Nicholas J. Singer |
| Left Lead | Maxim |
| IPO Cash in Trust | 102.2% |
| SPAC Tenor | 18 months |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Comera Life Sciences |
| Deal Announced | Jan 31, 2022 |
| Deal Size, $M | $151.30M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | May 10, 2022 |
| Amendment Vote | TBD |
| Closing Date | May 19, 2022 |
Formerly OTRA
CMRA
CMRAW
| Price | $0.00 |
|---|---|
| Last closing price | $0.22 |
| H/L, today | $0.00 / $0.00 |
| H/L, 52-week | $0.22 / $2.17 |
| Volume, today | 118,900 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.